I am a Research Fellow within the Centre for 21st Century Public Health, where I lead its Academy for ECRs and contribute to research coordination efforts across its diverse research projects. I am also President of ICARA, an international research network focused on building capacity and addressing the dearth in evidence on the commercial determinants of health in low-and-middle-income countries.

Currently, I serve as the Research Staff Representative on the Department for Health's Knowledge Exchange and Research Committee. In this role, I organise our monthly departmental rounds and ensure that research staff concerns are integrated into departmental planning around knowledge exchange and impact.

My research focuses on the regulation and political influence of diverse health-harming industries, concentrating principally on issues related to coordination and coherence. I predominately work on cannabis, leading the development of a distinctive and highly influential series of papers on emerging regulatory frameworks for cannabis policy and their implications for health and nascent industry. Furthermore, I was sole author on two studies exploring coordination challenges and the constraints imposed by broader regional and international drug and finance agreements in the development of Uruguay’s cannabis regulation.

I led the development and authorship of the first two comparative studies on the institutional and organisational barriers to implement measures to minimise tobacco industry interference across four UK Overseas Territories and five LMICs, published as part of a special issue for Tobacco Control. Recently, I have expanded her research profile to include other health-harming industries such as  pesticides, ultra-processed foods and fossil fuels.

My work has stimulated extensive academic and policy discussions on the health implications of commercial cannabis markets, and informed public health policy at a range of levels from national to local. My comparative analysis of state-level cannabis policymaking informed several follow-up studies, including guidelines for reducing health harms of cannabis, an assessment of policy options for cannabis reform in New Zealand and a comparative analysis of the efficacy of US state-level cannabis policies. My research has also received significant media coverage and I have been interviewed by several high-profile news outlets, including Time Magazine, Rolling Stone, Vice News, Los Angeles Times, Air Talk and Healthline.

Several key institutions and decision-making bodies have drawn on my published research, including the Royal College of Physicians, American College of Physicians, US National Association of County and City Health Officials and the Massachusetts Prevention Alliance. This work also led to invitations to contribute to key policy initiatives via roles that reflect the significance and policy influence of my published research, including as commissioned policy advisor for Health Canada’s Cannabis Regulation and Legalization Secretariat and advisory committee member on California Governor Newsom’s Blue Ribbon Commission on Marijuana Policy